Welcome to LookChem.com Sign In|Join Free
  • or
1-(tert-butoxycarbonylamino)-4-bromo-7-benzyloxycarbonylamino-5,7,8,9-tetrahydro-6H-benzocyclohepten-6-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1257872-22-2

Post Buying Request

1257872-22-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1257872-22-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1257872-22-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,7,8,7 and 2 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1257872-22:
(9*1)+(8*2)+(7*5)+(6*7)+(5*8)+(4*7)+(3*2)+(2*2)+(1*2)=182
182 % 10 = 2
So 1257872-22-2 is a valid CAS Registry Number.

1257872-22-2Relevant academic research and scientific papers

Regioselective synthesis of the 1-bromo-4-phenyl-tetrahydro-7-amino- benzocyclohepten-6-one, a subnanomolar aminopeptidase-N/CD13 inhibitor

Al-Lakkis-Wehbe, Mira,Roux, Lionel,Charrier, Cédric,Alavi, Sarah,Le Nou?n, Didier,Defoin, Albert,Tarnus, Céline,Albrecht, Sébastien

experimental part, p. 6447 - 6455 (2012/08/28)

A regioselective synthesis of the title 1-bromo-4-phenyl-tetrahydro-7- amino-benzocyclohepten-6-one 2 has been pursued and develop in order to allow a large scale synthesis of this highly potent and selective APN inhibitor (K i 60 pM). The pivo

Iodine(III)-mediated ring expansion: An efficient and green pathway in the synthesis of a key precursor for the design of aminopeptidase (APN or CD13) inhibitors

Roux, Lionel,Charrier, Cédric,Defoin, Albert,Bisseret, Philippe,Tarnus, Céline

experimental part, p. 8722 - 8728 (2011/01/04)

Iodine(III)-mediated ring expansion of a methylidenebenzocyclohexane derivative into the corresponding benzosuberone was used as a key reaction for the obtention of an important precursor for the design of aminopeptidase (APN or CD13) inhibitors. It represents the first application of this environmentally friendly rearrangement to medicinal chemistry.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1257872-22-2